Effectiveness of Acupuncture for Depressed Patients Not Taking Antidepressant Medications
Effectiveness of Acupuncture on Treating Major Depressive Disorder
1 other identifier
interventional
64
1 country
1
Brief Summary
Acupuncture is a popular complementary/alternative therapy that has been in use for thousands of years for the treatment of various medical and psychiatric conditions, including Major Depressive Disorder (MDD). In this study, the investigators applied the investigators acupuncture-treatment-for-depression protocol, based on Traditional Chinese Medicine (TCM) principles for treating MDD, to depressed patients not taking any antidepressant medications (a protocol that the investigators previously piloted as a medication augmentation therapy for partial responders with MDD). The investigators specifically investigated the efficacy, safety, and tolerability of this TCM-based protocol for such patients, as well as potential differences in outcomes between weekly vs. twice-weekly treatment. The investigators hypothesized that acupuncture monotherapy would be associated with a response rate of at least 50%, which the investigators defined as a decrease in depressive symptoms from the beginning to the end of the study of 50% or more, and that the response would be greater among patients who received acupuncture 2 times per week (vs. 1 time per week). The investigators also hypothesized that acupuncture would be associated with minimal side effects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable depression
Started May 2005
Longer than P75 for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2011
CompletedFirst Submitted
Initial submission to the registry
June 15, 2012
CompletedFirst Posted
Study publicly available on registry
July 6, 2012
CompletedJuly 6, 2012
July 1, 2012
6.5 years
June 15, 2012
July 2, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in scores on the Hamilton Depression Rating Scale, 17 items (HAM-D-17)
The HAM-D-17 is a clinician-rated assessment (structured interview) of patients' depressive symptoms. Questions focus on depressive symptoms during the past 7 days, and higher cumulative scores (possible responses to each item range from 0-4 or 0-2) indicate more severe depression.
Baseline and all acupuncture sessions (weekly) for 8 weeks
Secondary Outcomes (1)
Response to treatment, defined as a 50% or greater improvement in HAM-D-17 score compared to baseline
Baseline and all acupuncture sessions (weekly) for 8 weeks
Study Arms (1)
Acupuncture
EXPERIMENTALAdults with depression who are not currently taking an antidepressant medication.
Interventions
5 specific body acupoints (HT-7 and LI-4 on the hands bilaterally, and ST-36, SP-6, and LR-3 on the legs bilaterally) with gentle manual tonification every 10 min. Two acupoints along the midline of the head, GV-20 and GV-24.5 (Yintang), were also used with a 2 Hz current applied from GV-20 (-) to GV24.5 (+).
Eligibility Criteria
You may qualify if:
- Has current or past DSM-IV MDD diagnosis based on SCID; AND current 17-Hamilton Rating Scale for Depression (BRSD) score of 14 or above
- Age between 18-65
- No treatment with antidepressant(s) in the past 3 months
- If patient has received psychotherapy, no initiation or termination of therapy in the past 3 months.
You may not qualify if:
- Patients with primary diagnosis other than Major Depressive Disorder, or any history of psychosis or mania.
- Conditions that could make it difficult to conclusively determine that depressive symptoms were the result of MDD and not some other condition, including substance abuse or dependence within the last 6 months, medical conditions that could produce depression, including epilepsy, history of an abnormal EEG, severe head trauma, or stroke.
- Serious uncontrolled medical conditions \[e.g. poorly controlled diabetes, severe congestive heart failure\], or other medical conditions that have not been stable for at least 3 months.
- Electroconvulsive therapy (ECT) during the last year.
- Current active suicidal or self-injurious potential necessitating immediate treatment.
- Currently receiving concomitant Acupuncture Treatment, or any Acupuncture treatment in the past three months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Depression Clinical and Research Program, Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Related Publications (1)
Mischoulon D, Brill CD, Ameral VE, Fava M, Yeung AS. A pilot study of acupuncture monotherapy in patients with major depressive disorder. J Affect Disord. 2012 Dec 10;141(2-3):469-73. doi: 10.1016/j.jad.2012.03.023. Epub 2012 Apr 21.
PMID: 22521855RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Albert Yeung, MD, ScD
Depression Clinical and Research Program, Massachusetts General Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Primary Care Research, Depression Clinical and Research Program
Study Record Dates
First Submitted
June 15, 2012
First Posted
July 6, 2012
Study Start
May 1, 2005
Primary Completion
November 1, 2011
Study Completion
November 1, 2011
Last Updated
July 6, 2012
Record last verified: 2012-07